Literature DB >> 3845820

Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?

W Augener, B Friedmann, G Brittinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3845820     DOI： 10.1007/bf00320302

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  8 in total

1.  Binding of aggregated IgG by lymphocytes in chronic lymphocytic leukemia.

Authors:  W Augener; G Cohnen; G Brittinger
Journal:  Biomedicine       Date:  1974-01-20

2.  Effect of intravenous immunoglobulin in immune thrombocytopenia.

Authors:  A Salama; C Mueller-Eckhardt; V Kiefel
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

3.  A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias.

Authors:  C Mueller-Eckhardt; A Salama; V Kiefel; E Küenzlen; C Förster
Journal:  Blut       Date:  1984-06

4.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

5.  Studies on the mechanism of heat aggregation of human gamma-G.

Authors:  W Augener; H M Grey
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

6.  The reaction of monomeric and aggregated immunoglobulins with C1.

Authors:  W Augener; H M Grey; N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1971-11

7.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Authors:  P Imbach; S Barandun; V d'Apuzzo; C Baumgartner; A Hirt; A Morell; E Rossi; M Schöni; M Vest; H P Wagner
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

8.  Treatment of refractory chronic idiopathic thrombocytopenic purpura with high dose intravenous immunoglobulin.

Authors:  E Seifried; G Pindur; H Stötter; M Wiesneth; H Rasche; H Heimpel
Journal:  Blut       Date:  1984-06
  8 in total
  8 in total

Review 1.  Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias.

Authors:  H I Atrah; R J Davidson
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

2.  Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.

Authors:  L Cook; J F Howard; J D Folds
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

3.  A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b.

Authors:  Hua Zhou; Henrik Olsen; Edward So; Emmanuel Mérigeon; Denis Rybin; Jane Owens; Gregory LaRosa; David S Block; Scott E Strome; Xiaoyu Zhang
Journal:  Blood Adv       Date:  2017-03-14

4.  Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  J Autoimmun       Date:  2014-01-02       Impact factor: 7.094

5.  Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes.

Authors:  T W Jungi; M Brcic; P Kuhnert; M O Spycher; F Li; U E Nydegger
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 6.  Novel Therapies to Address Unmet Needs in ITP.

Authors:  María Eva Mingot-Castellano; José María Bastida; Gonzalo Caballero-Navarro; Laura Entrena Ureña; Tomás José González-López; José Ramón González-Porras; Nora Butta; Mariana Canaro; Reyes Jiménez-Bárcenas; María Del Carmen Gómez Del Castillo Solano; Blanca Sánchez-González; Cristina Pascual-Izquierdo
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-23

7.  Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice.

Authors:  Ajay Jain; Henrik S Olsen; Ravi Vyzasatya; Erin Burch; Yukimi Sakoda; Emmanuel Y Mérigeon; Ling Cai; Changwan Lu; Ming Tan; Koji Tamada; Dan Schulze; David S Block; Scott E Strome
Journal:  Arthritis Res Ther       Date:  2012-08-20       Impact factor: 5.156

Review 8.  High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.

Authors:  Xiaosheng Liu; Wei Cao; Taisheng Li
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.